|
3
Votes
vote
Results out from first phase III randomized clinical trial to study the best time to begin ART in infantsTesting very young babies for HIV and giving antiretroviral therapy (ART) immediately to those found infected with the virus dramatically prevents illness and death, according to a report in the New England Journal of Medicine. ... |
|
0
Votes
vote
BehindTheMedspeak: Genetic PaparazziLet's give credit where credit is due to Dr. Kathy Hudson, founder and director of Johns Hopkins University's Genetics and Public Policy Center in Washington, D.C., for coining the great phrase in the headline above. I saw it for the very first time ever in today's fascinating USA Today story ... |
|
0
Votes
vote
Abdominal adiposity and risk of death, or "belly fat'll kill ya'" [denialism blog]Last week's New England Journal of Medicine gave us some remarkable news, via the JUPITER Trial, adding additional evidence to the pile of articles on the cardioprotective effects of statins. This article is getting lots of press, which is great, but I'd hate to see this week's edition of th... |
|
2
Votes
vote
Important New Study: Belly Fat Doubles Risk Of Early DeathBelly fat has been linked to an increased risk of heart disease and diabetes. Now an important new study links belly fat to early death. Researchers followed about 360,000 Europeans enrolled in one of the largest and longest health studies in the world. They found that people with the most belly f ... |
|
0
Votes
vote
A large waistline doubles your risk of premature deathHaving a large waistline can almost double your risk of dying prematurely even if your body mass index is within the 'normal' range, according to a new study of over 350,000 people across Europe, published in the New England Journal of Medicine. ... |
|
0
Votes
vote
Media Reports on Pharmaceuticals may be Skewed towards Commercial Interests(NaturalNews) We are continually, from time to time, informed about how some supposedly independent researchers had in fact received undisclosed payouts from pharmaceutical companies. In more disconcerting news about the undesirable influence of pharmaceutical companies, a review published in the... |

